Adverse Drug Reactions Of Cardiovascular Drugs In Intensive Cardiac Care Unit In A Tertiary Care Hospital: A Prospective Study

Author:

Shanmugam Hemanthkumar1,Panneerselvam Nithya2,Amutha Lawrence Arul3

Affiliation:

1. Department of Pharmacology, Meenakshi Ammal Dental College, MAHER, Chennai, India.

2. Department of Pharmacology, Meenakshi Medical College and Hospital, MAHER, Kanchipuram, India.

3. Department of Pharmacology, Sree Balaji Medical College and Hospital, Bharath University, Chennai, India.

Abstract

Cardiovascular diseases are prevalent in developing countries like India. Patients with cardiovascular diseases are prescribed multiple drugs, hence polypharmacy may attribute to higher incidence of adverse drug reactions in these patients. To monitor and to analyze the pattern of occurrence of adverse drug reactions reported with cardiovascular drugs in intensive cardiac care unit of a tertiary care hospital, Chennai. This was a prospective surveillance study carried out for a period of 6 months. Analysis of various adverse drug reactions reported were done using various assessment scales. Descriptive statistics was used and values were expressed in numbers and percentage. During the study period, 282 adverse reactions were reported from 389 patientsat includes 232 males and 157 females. The average age of the patients included in this study was 58.1± 16.8 years . The most common ADRs observed were electrolyte imbalance (14.89%), headache (13.12%) and gastritis (12.41%). Assessment using WHO Causality assessment scale revealed 60.28% were possible, 18.43% probable, 12.76% certain and 8.51% unlikely. According to Schumock and Thornton scale 65.9% of ADRs were preventable and 34% non preventable. Analysis with Hartwig and Seigel’s scale 62.05% of ADRs were moderate in severity, 27.95% mild and 10.99% severe. Drugs attributing to highest ADRs were Digoxin and Furosemide. The common ADRs due to cardiovascular drugs can be reduced by improving the prescription pattern. Intense monitoring and reporting of ADRs could help in minimizing the preventable ADRs, among the health care professionals.

Publisher

Oriental Scientific Publishing Company

Subject

Pharmacology

Reference27 articles.

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics: a report from the American Heart Association. Circulation. 2014; 29: 322-8.

2. Krishnan MN. Coronary heart disease and risk factors in India – On the brink of an epidemic? Indian Heart Journal. 2012; 64: 364-7.

3. WHO Media center. Fact sheet: cardiovascular diseases (CVDs), 2016. Available at: http://www.who.int/mediacentre/factsheets/fs317/en. Accessed 27 October 2016

4. Tripathi K.D , Essentials of Medical Pharmacology, Seventh edition, New Delhi., Jaypee Publishers 2013.

5. Zaki SA. Adverse drug reactions and causality assessment scales. Lung India. 2011; 28 (2):152-3.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3